摘要
分子检测技术在女性肿瘤早期筛查、指导治疗药物选择、预测预后和疗效监测等方面显示出良好的应用前景与广阔发展。大量研究表明分子检测结果具有影响乳腺癌、子宫颈癌、子宫内膜癌与卵巢癌等女性肿瘤诊疗策略的巨大潜力。先前人乳头瘤病毒检测对于宫颈癌筛查、人乳腺癌易感1/2号基因突变易感基因检测预测乳腺癌风险与用药指导奠定了女性肿瘤分子检测临床应用基础,并展现新型分子检测的研究在未来女性肿瘤诊疗中的临床应用前景。
The molecular detection technology shows a better application prospect and broad development in the early screening of female tumors,guiding the selection of therapeutic drugs,predicting prognosis and monitoring the efficacy of treatment.Numerous studies have demonstrated that molecular detection has great impact on the diagnosis and treatment strategies of female tumors such as breast cancer,cervical cancer,endometrial cancer and ovarian cancer.Previously,human papilloma virus detection has laid a foundation for clinical application for cervical cancer screening and breast cancer 1/2 mutation susceptibility gene detection to predict the risk of breast cancer and give drug guidance.These studies show the clinical application prospect of new molecular detection in the diagnosis and treatment of female tumors in the future.
作者
谢小兵
刘禹利
Xie Xiaobing;Liu Yuli(Medical Laboratory and Pathology Center,the First Hospital of Hunan University of Chinese Medicine,Changsha 410007,China;Precision Medicine Center,the First Affiliated Hospital of Guangdong Pharmaceutical University,Guangzhou 510000,China)
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2023年第4期331-333,共3页
Chinese Journal of Laboratory Medicine
关键词
分子诊断技术
乳腺肿瘤
宫颈肿瘤
子宫内膜肿瘤
卵巢肿瘤
Molecular diagnostic techniques
Breast neoplasms
Uterine cervical neoplasms
Endometrial neoplasms
Ovarian neoplasms